But theyre licensed for different uses in the UK: Ozempic for Type 2 Diabetes, and Wegovy for weight loss in people with a BMI 27 (with conditions) or 30
You know, they might measure your fat body mass or do something to purportedly measure, you know, your metabolism, this kind of thing to justify whatever it is theyre going to do
To qualify, patients must: Be 18 years or older, non-pregnant Have a Body Mass Index (BMI) of 30 kg/m, or Have a BMI of 25 kg/m with at least one obesity-related risk factor (e.g., hypertension, diabetes) While semaglutide is an effective weight management tool, it is not for everyone
Chronic Weight Management: In June 2021, the FDA approved semaglutide (Wegovy) at a higher dose of 2.4 mg for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity, such as type 2 diabetes, hypertension, or dyslipidemia